Basic Information
| RNALocate ID: | RLID:11003665 |
| RNA Symbol: | hsa-miR-181a-2-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-181a-2-3p |
| RNA ID: | miRBase:MIMAT0004558 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002593 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID-D:11000184 | Exosome | B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue | |
| RLID-D:11000604 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-181a-2-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-19387 |
| MNDR | hsa-miR-181a-2-3p | Lymphoma | MNDR-E-MI-19388 |
| MNDR | hsa-miR-181a-2-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-19389 |
| MNDR | hsa-miR-181a-2-3p | Prostate cancer | MNDR-E-MI-19390 |
| MNDR | hsa-miR-181a-2-3p | Gastric cancer | MNDR-E-MI-19391 |
| MNDR | hsa-miR-181a-2-3p | Alzheimer disease | MNDR-E-MI-19392 |
| MNDR | hsa-miR-181a-2-3p | Intracranial aneurysm | MNDR-E-MI-19393 |
| MNDR | hsa-miR-181a-2-3p | Ataxia telangiectasia | MNDR-E-MI-19394 |
| MNDR | hsa-miR-181a-2-3p | Cardiovascular disease | MNDR-E-MI-19395 |
| MNDR | hsa-miR-181a-2-3p | Lung cancer | MNDR-E-MI-19396 |
| MNDR | hsa-miR-181a-2-3p | Parkinson disease | MNDR-E-MI-19397 |
| MNDR | hsa-miR-181a-2-3p | Basal-like breast cancer | MNDR-E-MI-19398 |
| MNDR | hsa-miR-181a-2-3p | Thyroid cancer | MNDR-E-MI-19399 |
| MNDR | hsa-miR-181a-2-3p | Pancreatic cancer | MNDR-E-MI-19400 |
| MNDR | hsa-miR-181a-2-3p | Melanoma | MNDR-E-MI-19401 |
| MNDR | hsa-miR-181a-2-3p | Rectum adenocarcinoma | MNDR-E-MI-19402 |
| MNDR | hsa-miR-181a-2-3p | Nephroblastoma | MNDR-E-MI-19403 |
| MNDR | hsa-miR-181a-2-3p | Colon cancer | MNDR-E-MI-19404 |
| MNDR | hsa-miR-181a-2-3p | Colon adenocarcinoma | MNDR-E-MI-19405 |
| MNDR | hsa-miR-181a-2-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-19406 |
| MNDR | hsa-miR-181a-2-3p | Carcinoma ductal breast | MNDR-E-MI-19407 |
| MNDR | hsa-miR-181a-2-3p | Glioblastoma | MNDR-E-MI-19408 |
| MNDR | hsa-miR-181a-2-3p | Glioma | MNDR-E-MI-19409 |
| MNDR | hsa-miR-181a-2-3p | Chordoma | MNDR-E-MI-19410 |
| MNDR | hsa-miR-181a-2-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-19411 |
| MNDR | hsa-miR-181a-2-3p | Osteosarcoma | MNDR-E-MI-19412 |
| MNDR | hsa-miR-181a-2-3p | Lung squamous cell carcinoma | MNDR-E-MI-19413 |
| MNDR | hsa-miR-181a-2-3p | Thyroid carcinoma | MNDR-E-MI-19414 |
| MNDR | hsa-miR-181a-2-3p | Bladder urothelial carcinoma | MNDR-E-MI-19415 |
| MNDR | hsa-miR-181a-2-3p | Pancreatic adenocarcinoma | MNDR-E-MI-19416 |
| MNDR | hsa-miR-181a-2-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-19417 |
| MNDR | hsa-miR-181a-2-3p | Carcinoma renal cell | MNDR-E-MI-19418 |
| MNDR | hsa-miR-181a-2-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-19419 |
| MNDR | hsa-miR-181a-2-3p | Renal clear cell carcinoma | MNDR-E-MI-19420 |
| MNDR | hsa-miR-181a-2-3p | Lung small cell carcinoma | MNDR-E-MI-19421 |
| MNDR | hsa-miR-181a-2-3p | Synovial sarcoma | MNDR-E-MI-19422 |
| MNDR | hsa-miR-181a-2-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-19423 |
| MNDR | hsa-miR-181a-2-3p | Breast invasive carcinoma | MNDR-E-MI-19424 |
| MNDR | hsa-miR-181a-2-3p | Hepatocellular carcinoma | MNDR-E-MI-19425 |
| MNDR | hsa-miR-181a-2-3p | Rheumatoid arthritis | MNDR-E-MI-19426 |
| MNDR | hsa-miR-181a-2-3p | Barrett's adenocarcinoma | MNDR-E-MI-19427 |
| MNDR | hsa-miR-181a-2-3p | Skin cutaneous melanoma | MNDR-E-MI-19428 |
| MNDR | hsa-miR-181a-2-3p | Skin melanoma | MNDR-E-MI-19429 |
| MNDR | hsa-miR-181a-2-3p | Colorectal cancer | MNDR-E-MI-19430 |
| MNDR | hsa-miR-181a-2-3p | Prostatic neoplasms | MNDR-E-MI-19431 |
| MNDR | hsa-miR-181a-2-3p | Barrett's carcinogenesis | MNDR-E-MI-19432 |
| MNDR | hsa-miR-181a-2-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-19433 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | PTEN | Homo sapiens | RR01151478 |
TOP